Japanese Paediatric Pharma Brand Seeks Mother and Baby Health Companies
- Reference
- BM-41
- Origin
- Japan
- Investor type
- Strategic buyer
- Sector
- Healthcare & Pharma
- Minimum revenue
- ≥ US$1.5M
- Stake sought
- 30–70%
- Ticket size
- —
- Geography
- Vietnam
Overview
Leading Japanese paediatric and family pharmaceutical brand acquiring or partnering with manufacturers and distributors.
What the investor looks for
- Paediatric pharma, supplements for children and pregnant women, mother-and-baby store networks
- Revenue of US$1.5–5M a year; stable net margin of 10–15%
- Proprietary formulas, product registrations or compliant warehousing and distribution
- Channels covering mother-and-baby chains, pharmacies or paediatric hospitals
- 30% (strategic partner) to 70% stake
Companies that may fit
USD figures are indicative, converted at about VND 25,500 per US$. Figures come from the seller and are unaudited.